Neoadjuvant chemotherapy with cisplatinum and 5-fluorouracil in advanced head and neck cancer. 1990

G Teatini, and F Meloni, and M Bisail, and V Milia, and G Sanna, and M G Sarobba, and B Massidda, and T Scotto, and A Farris
Department of Otorhinolaryngology, University of Sassari, Italy.

Forty-one patients affected by solid tumors of the head and neck were treated with neoadjuvant therapy before radiotherapy or surgery. All patients received therapy with cisplatinum 100 mg/m2 day 1 and 5-fluorouracil 1000 mg/day for days 1-5 by continuous infusion with a portable chronoinfusor. After three cycles, we observed an objective response in 34/41 patients (82.9%), with 9 (21.9%) complete remissions and 25 (61%) partial remissions. The main side effects were few and controllable. In our experience, neoadjuvant chemotherapy was able to induce a significant remission in 4/5 of patients, with better prospects for subsequent surgery and/or radiotherapy.

UI MeSH Term Description Entries
D008297 Male Males
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

G Teatini, and F Meloni, and M Bisail, and V Milia, and G Sanna, and M G Sarobba, and B Massidda, and T Scotto, and A Farris
November 1993, Oncology,
G Teatini, and F Meloni, and M Bisail, and V Milia, and G Sanna, and M G Sarobba, and B Massidda, and T Scotto, and A Farris
August 1996, American journal of clinical oncology,
G Teatini, and F Meloni, and M Bisail, and V Milia, and G Sanna, and M G Sarobba, and B Massidda, and T Scotto, and A Farris
July 1997, Annals of oncology : official journal of the European Society for Medical Oncology,
G Teatini, and F Meloni, and M Bisail, and V Milia, and G Sanna, and M G Sarobba, and B Massidda, and T Scotto, and A Farris
January 2012, American journal of otolaryngology,
G Teatini, and F Meloni, and M Bisail, and V Milia, and G Sanna, and M G Sarobba, and B Massidda, and T Scotto, and A Farris
January 1988, Advances in experimental medicine and biology,
G Teatini, and F Meloni, and M Bisail, and V Milia, and G Sanna, and M G Sarobba, and B Massidda, and T Scotto, and A Farris
December 1991, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
G Teatini, and F Meloni, and M Bisail, and V Milia, and G Sanna, and M G Sarobba, and B Massidda, and T Scotto, and A Farris
January 1997, Seminars in surgical oncology,
G Teatini, and F Meloni, and M Bisail, and V Milia, and G Sanna, and M G Sarobba, and B Massidda, and T Scotto, and A Farris
March 1995, Journal of the Formosan Medical Association = Taiwan yi zhi,
G Teatini, and F Meloni, and M Bisail, and V Milia, and G Sanna, and M G Sarobba, and B Massidda, and T Scotto, and A Farris
May 1988, Journal of surgical oncology,
G Teatini, and F Meloni, and M Bisail, and V Milia, and G Sanna, and M G Sarobba, and B Massidda, and T Scotto, and A Farris
February 1994, American journal of clinical oncology,
Copied contents to your clipboard!